MedTrace Logo

Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy

NCT01113736 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-05-12

No results posted yet for this study

Summary

The objective of this study is to investigate whether the use of Human Peritoneal Membrane (HPM) in a temporary loop ileostomy is beneficial to patients. Benefit will be defined, for purposes of this study, as a decrease in adhesions resulting in decreased operative time during ileostomy closure, with promotion of peritoneal remodeling.

Conditions

Interventions

BIOLOGICAL

AlloMEM™

To investigate whether the use of HPM in a temporary loop ileostomy is beneficial to patients.

Sponsors & Collaborators

  • Proxy Biomedical Limited

    collaborator UNKNOWN

  • University Hospitals Cleveland Medical Center

    lead OTHER

Principal Investigators

  • Conor P. Delaney, MD, PhD · University Hospitals Cleveland Medical Center

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01113736 on ClinicalTrials.gov